Sage Journals: Discover world-class research

Open access

Review article

First published 2025

Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressants

S Clare Stanford

Journal of Psychopharmacology

Open access

Review article

First published 2020

Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms

Matteo Marcatili, Carlo Sala, Antonios Dakanalis [...]

Therapeutic Advances in Psychopharmacology

Open access

Review article

First published 2019

Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators

Anderson Camargo, Ana Lúcia S. Rodrigues

Chronic Stress

Retricted access

Research article

First published 2020-4

Translocator protein–mediated fast-onset antidepressant-like and memory-enhancing effects in chronically stressed mice

Chao Shang, Ru-Meng Yao, Ying Guo [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 2021-4

Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action

Rafael Guimarães dos Santos, Jaime EC Hallak, Glen Baker [...]

Journal of Psychopharmacology

Open access

Article commentary

First published 2018

Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics

David E Olson

Neuroscience Insights

Retricted access

Research article

First published 2019-1

Anemoside A3 rapidly reverses depression-like behaviors and weakening of excitatory synaptic transmission in mouse models of depression

Can-Ming Wang, Zhi-Hang Lin, Zhi-Qiang Lin [...]

Journal of Psychopharmacology

Open access

Research article

First published 2026-3

Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l’étude CAN-BIND-1

Chloé Stengel, Benjamin Schwartzmann, Raaj Chatterjee [...]

The Canadian Journal of Psychiatry

Open access

Review article

First published 2021

MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants

Tomasz Cholewinski, Diana Pereira, Matthijs Moerland [...]

Therapeutic Advances in Psychopharmacology

Open access

Research article

First published 2021

Resting-state connectivity studies as a marker of the acute and delayed effects of subanaesthetic ketamine administration in healthy and depressed individuals: A systematic review

Vasileia Kotoula, Toby Webster, James Stone [...]

Brain and Neuroscience Advances

Search results